Clinical study of calcium channel blockers in patients with chronic kidney disease

Clinical study of calcium channel blockers in patients with chronic kidney disease - Clinical study of CCBs

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002644

Enrollment

200

Registered

2009-10-25

Start date

2008-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

benidipine amlodipine cilnidipine azelnidipine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)CKD stage 3-5 2)Hypertension; more than 130/80mmHg 3)Urinary protein/creatinine ratio; more than 300mg/gCr

Exclusion criteria

Exclusion criteria: 1)hypertensive emergency; 2) history of severe heart failure, angina, myocardial infarction, or stroke within 6 months before the start of the trial; 3) previous treatment with steroids or immunosuppressants; 4) renovascular hypertension or endocrine hypertension; 5) severe diabetes mellitus that led to hospitalization because of extremely high plasma glucose or that was associated with complications such as diabetic ketoacidosis.

Design outcomes

Primary

Measure	Time frame
renal function, urinary protein excretion, blood pressure	—

Countries

Japan

Contacts

Public ContactMasanori Abe

Nihon University Nerima Hikarigaoka Hospital Internal medicine

mabe@med.nihon-u.ac.jp03-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026